Delanaye Pierre, Krzesinski François, Dubois Bernard E, Delcour Alexandre, Robinet Sébastien, Piette Caroline, Krzesinski Jean-Marie, Lancellotti Patrizio
Department of Nephrology, Dialysis, Transplantation, University of Liège (ULg CHU), CHU Sart Tilman, Liège, Belgium.
GIGA Cardiovascular Sciences, University of Liège (ULg CHU), CHU Sart Tilman, Liège, Belgium.
Clin Kidney J. 2019 Nov 26;14(1):390-397. doi: 10.1093/ckj/sfz157. eCollection 2021 Jan.
Sudden death is frequent in haemodialysis (HD) patients. Both hyperkalaemia and change of plasma potassium (K) concentrations induced by HD could explain this. The impact of increasing dialysate K by 1 mEq/L on plasma K concentrations and electrocardiogram (ECG) results before and after HD sessions was studied.
Patients with pre-dialysis K >5.5 mEq/L were excluded. ECG and K measurements were obtained before and after the first session of the week for 2 weeks. Then, K in the dialysate was increased (from 1 or 3 to 2 or 4 mEq/L, respectively). Blood and ECG measurements were repeated after 2 weeks of this change.
Twenty-seven prevalent HD patients were included. As expected, a significant decrease in K concentrations was observed after the dialysis session, but this decrease was significantly lower after the switch to an increased dialysate K. The pre-dialysis K concentrations were not different after changing, but post-dialysis K concentrations were higher after switching (P < 0.0001), with a lower incidence of post-dialysis hypokalaemia. Regarding ECG, before switching, the QT interval (QT) dispersion increased during the session, whereas no difference was observed after switching. One week after switching, post-dialysis QT dispersion [38 (34-42) ms] was lower than post-dialysis QT dispersion 2 weeks and 1 week before switching [42 (38-57) ms, P = 0.0004; and 40 (35-50) ms, P = 0.0002].
A simple increase of 1 mEq/L of K in the dialysate is associated with a lower risk of hypokalaemia and a lower QT dispersion after the dialysis session. Further study is needed to determine if such a strategy is associated with a lower risk of sudden death.
血液透析(HD)患者猝死很常见。高钾血症和HD引起的血浆钾(K)浓度变化都可能是其原因。本研究探讨了将透析液钾浓度提高1 mEq/L对HD治疗前后血浆K浓度和心电图(ECG)结果的影响。
排除透析前血钾>5.5 mEq/L的患者。在2周内每周的第一次治疗前后进行ECG和血钾测量。然后,将透析液中的钾浓度提高(分别从1或3 mEq/L提高到2或4 mEq/L)。在这种变化2周后重复进行血液和ECG测量。
纳入27例维持性HD患者。正如预期的那样,透析治疗后血钾浓度显著降低,但在透析液钾浓度升高后,这种降低显著减少。改变透析液钾浓度后,透析前血钾浓度无差异,但透析后血钾浓度在改变后更高(P<0.0001),透析后低钾血症的发生率更低。关于ECG,在改变透析液钾浓度之前,透析过程中QT间期(QT)离散度增加,而改变后未观察到差异。改变透析液钾浓度1周后,透析后QT离散度[38(34-42)ms]低于改变前2周和1周的透析后QT离散度[42(38-57)ms,P=0.0004;和40(35-50)ms,P=0.0002]。
透析液中钾浓度简单增加1 mEq/L与透析后低钾血症风险降低和QT离散度降低相关。需要进一步研究以确定这种策略是否与猝死风险降低相关。